Sandoz in the US
Sandoz is one of the largest manufacturers of generic pharmaceutical products in the United States, in business since 1946. We develop, manufacture, and distribute competitive, high-quality pharmaceuticals, standing out in the industry due to our focus on a wide range of differentiated products, ranging from complex delivery systems to modern biopharmaceutical medicines ("follow-on biologics" or "biosimilars").
Sandoz markets approximately 200 different generic medicines in the US, including enoxaparin sodium injection, the first generic version of Lovenox®, and Omnitrope®, the first follow-on biologic available in the US. Our approximately 1,300 US associates are proud to make Sandoz a “healthy decision” for patients, healthcare professionals, and the customers who distribute our products in the US.
Beyond the US, Sandoz, a Division of the Novartis Group (Novartis AG-NYSE: NVS), is a global leader in the field of generic pharmaceuticals, developing, manufacturing and increasing access to a wide array of high-quality, affordable medicines. The company has a portfolio of approximately 1,000 compounds and sells its products in more than 130 countries.
Broad PortfolioSandoz develops, produces, and markets medicines that range across many therapeutic drug categories:
- Central nervous system disorder treatments
- Cardiovascular medicines
- Gastrointestinal agent
- Oncology therapies
- Respiratory therapies
A virtual journey into the historical roots of our company.
See below for a list of special notices.